While the FDA does not regulate the potency of vitamin D supplements, companies can comply with the standards of the United States Pharmacopeial Convention, which requires that pills have at least 90% to 110% of the listed potency. Recently, results of a study were published online in JAMA Internal Medicine. The study found that pills from bottles made by a single manufacturer, but in varying lots had potencies as low as 9%, and as high as 140% of the listed dose. When the dosages of five pills from 5 separate bottles were averaged, the researchers found that only two-thirds met the U.S. Pharmacopeial Convention standard. High-performance liquid chromatography was used to analyze pills in 55 bottles of vitamin D bought at five stores in Portland, Oregon. Dr. Erin S. LeBlanc, lead author of the study, and researcher at Kaiser Permanente in Portland suggests looking for the U.S. Pharmacopeial Convention seal when purchasing vitamins. She said, “If you have a bottle with the U.S.P. stamp on it, you can feel reassured that what’s listed on the label is actually in the bottle.” nytimes.com 2/19/13
Archives
Top Posts
- "A Cup of Tea is Like Adding a Serving of Fruit or Vegetables to Your Diet"
- Turmeric (Curcumin) Capsules for Headaches and Arthritis Migraine blog
- New Butalbital Product(similar to Fioricet/Fiorinal/Esgic/Phrenilin)
- "Migraine And Anxiety: Understanding The Link And How To Break It"
- Headaches and Melatonin
- Are Pomegranates Good For You?
- CGRP QUESTIONS/ANSWERS
- CGRP AND SIDE EFFECTS: LETTER IN ‘HEADACHE”
Topics
adolescents
Alzheimer's disease
Alzheimers
anxiety
back pain
blood pressure
botox
brain
caffeine
children
chronic migraine
chronic pain
cluster headache
concussion
concussions
COVID-19
dementia
depression
diet
exercise
fibromyalgia
Headache
headache blog
headaches
health
heart disease
meditation
men
migraine
migraine headache
migraine headaches
migraines
migraine triggers
migraine with aura
pain
physical activity
sleep
stress
stroke
triggers
triptans
vitamin D
walking
women
yoga